Vascular Access Procedures Market Size & Growth Forecast 2027–2036, By Segments (Procedure Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Vascular Access Procedures Market size was more than USD 99.06 billion in 2026 and is set to grow at a 5.62% CAGR between 2027 and 2036, surpassing USD 171.14 billion by 2036. The industry revenue for 2027 is calculated at USD 103.79 billion.
Get more details on this report
Request Free Sample ReportVascular Access Procedures Market Intelligence Snapshot
Regional Market Dynamics
- North America held 42.66% of the market in 2026, supported by advanced healthcare infrastructure, high hospital procedure volumes, specialized clinical expertise, and established adoption of minimally invasive techniques.
- Expanding hospitals, rising patient volumes, and increasing demand for chronic disease treatment are strengthening procedural needs, while improved medical training and infection prevention practices support wider adoption.
Segment Momentum
- Arteriovenous fistulas account for 69.02% of the market in 2026 and are also the fastest-growing procedure type, supported by their durable vascular access, reliable blood flow, and suitability for long-term hemodialysis.
- Hemodialysis accounts for 55% of the market in 2026 and is also the fastest-growing application, driven by increasing demand for chronic kidney disease treatment and reliable vascular access for repeated dialysis sessions.
Market Expansion Drivers
- Rising prevalence of chronic diseases requiring vascular access.
- Technological advancements in vascular access devices.
- Expansion of hospitals and clinics in emerging markets.
Leading Market Participants
- Leading companies in the vascular access procedures market include Becton Dickinson (USA), B. Braun (Germany), Teleflex (USA), Medtronic (Ireland), Smiths Medical (UK), AngioDynamics (USA), Cook Medical (USA), Fresenius Medical Care (Germany), Nipro Corporation (Japan), Terumo (Japan).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 99.06 billion
- 2027 Estimated Market Size: USD 103.79 billion
- Projected Market Size: USD 171.14 billion by 2036
- Growth Forecast: 5.62% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Procedure Type (Arteriovenous Fistulas) | Application (Hemodialysis)
- Emerging Opportunity Segment: Procedure Type (Arteriovenous Fistulas) | Application (Hemodialysis)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic diseases requiring vascular access
The rising prevalence of chronic diseases requiring repeated or long-term medical treatment is increasing the need for reliable vascular access procedures. Patients undergoing therapies such as dialysis, intravenous medication, chemotherapy, and nutritional support often require dependable access to the vascular system, creating sustained demand for vascular access interventions. The growing emphasis on effective treatment delivery and continuity of care is encouraging healthcare providers to adopt appropriate vascular access approaches across acute and long-term care settings.
Technological advancements in vascular access devices
Technological advancements in vascular access devices are supporting market growth by improving the safety, usability, and clinical performance of vascular access procedures. Innovations in catheter design, access technologies, visualization methods, and infection prevention features are helping healthcare professionals address procedural challenges and reduce complications. Continued development of patient-focused and minimally invasive solutions is also encouraging adoption as healthcare providers seek more reliable approaches for vascular access management.
Expansion of hospitals and clinics in emerging markets
The expansion of hospitals and clinics in emerging markets is increasing access to specialized medical procedures, including vascular access interventions. Growing healthcare infrastructure, improved availability of diagnostic and treatment services, and broader adoption of advanced clinical practices are enabling more patients to receive therapies that require vascular access. As healthcare systems strengthen their capacity to manage chronic and complex conditions, demand for vascular access procedures is expected to expand alongside the development of specialized treatment facilities.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic diseases requiring vascular access | 2% | Short term (≤ 2 yrs) | North America; Europe | Medium | Fast |
| Technological advancements in vascular access devices | 1.8% | Medium term (2–5 yrs) | Europe; Asia Pacific | Medium | Moderate |
| Expansion of hospitals and clinics in emerging markets | 1.7% | Long term (5+ yrs) | Asia Pacific; Latin America | Medium | Moderate |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for 42.66% share of the vascular access procedures market in 2026, supported by advanced healthcare infrastructure, a high volume of hospital-based procedures, and established adoption of minimally invasive vascular access techniques. The region benefits from specialized medical facilities, experienced healthcare professionals, and widespread availability of advanced technologies used to establish and manage vascular access for patients requiring medication delivery, fluid administration, blood sampling, and other clinical interventions. Growing demand for long-term and reliable vascular access among patients undergoing complex treatments is supporting procedure volumes across hospitals and specialized care settings. Increasing emphasis on patient safety, infection prevention, and efficient clinical workflows is also encouraging healthcare providers to adopt improved access techniques and technologies. In addition, the expansion of outpatient care and the increasing use of image-guided procedures are supporting the broader adoption of advanced vascular access approaches.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is expected to be the fastest-growing region in the vascular access procedures market, propelled by expanding healthcare infrastructure, rising patient volumes, and improving access to advanced medical procedures. Growing investments in hospitals and specialized treatment centers are increasing the availability of vascular access services across emerging healthcare markets. The rising prevalence of chronic diseases requiring prolonged treatment and repeated hospital care is also contributing to demand for reliable vascular access procedures. Improvements in healthcare delivery, medical training, and procedural technologies are encouraging broader adoption of modern access techniques. In addition, increasing awareness of infection prevention and patient safety is driving healthcare providers to improve vascular access practices and adopt technologies that support more consistent and efficient procedures. The continued expansion of specialized healthcare services is expected to strengthen demand across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Advanced Access AdoptionThe U.S. market emphasizes ultrasound-guided access, catheter-based techniques, infection prevention, and workflow efficiency across hospitals and outpatient settings. Priorities include improving first-attempt success, reducing complications, and supporting clinician adoption of advanced access devices and standardized procedural protocols.
Germany 🇩🇪
Procedure StandardizationGermany’s vascular access priorities center on standardized clinical protocols, infection control, and efficient catheter management across hospital settings. Providers can strengthen market relevance through technologies that improve procedural consistency, support ultrasound-guided placement, and reduce device-related complications while fitting established clinical workflows.
Japan 🇯🇵
Minimally Invasive AccessJapan’s vascular access landscape favors minimally invasive techniques and dependable catheter management suited to an aging patient population and complex care pathways. Commercial priorities include smaller and easier-to-use devices, ultrasound-assisted procedures, infection prevention, and technologies that reduce complications during prolonged vascular access.
South Korea 🇰🇷
Technology-Enabled ProceduresSouth Korea’s market priorities include advanced imaging-assisted vascular access, procedural efficiency, and improved catheter safety in hospital care. Suppliers can focus on devices and technologies that simplify placement, enhance procedural precision, and support infection-control practices across increasingly technology-oriented clinical environments.
France 🇫🇷
Safety-Focused Access CareFrance emphasizes safe vascular access practices, infection prevention, and standardized catheter management across healthcare facilities. Market opportunities center on technologies that improve placement accuracy and reduce complications, while supporting clinicians with practical procedural tools compatible with established hospital protocols.
Italy 🇮🇹
Efficient Hospital AccessItaly’s vascular access market prioritizes reliable procedures, catheter safety, and efficient hospital resource utilization. Suppliers can address demand through accessible ultrasound-guided technologies, improved catheter designs, and solutions that reduce insertion difficulties and complications while fitting diverse hospital operating environments.
Vascular Access Procedures Market Share (%), by Procedure Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProcedure Type Segment Analysis: Arteriovenous Fistulas (Largest & Fastest-Growing Segment)
Arteriovenous fistulas accounted for the largest share of 69.02% in 2026 and are also expected to grow at the fastest rate during the forecast period in the vascular access procedures market. Arteriovenous fistulas are widely used for patients requiring long-term hemodialysis because they provide durable vascular access and can support repeated dialysis treatments over extended periods. Their ability to deliver reliable blood flow while generally offering favorable long-term performance makes them an important option for patients with chronic kidney disease who require ongoing renal replacement therapy. The growing burden of kidney disorders and increasing number of patients requiring regular dialysis are supporting continued demand for dependable vascular access procedures. Healthcare providers also emphasize the preservation of vascular access and reduction of complications associated with repeated treatment, encouraging the use of established access approaches. Improvements in surgical techniques, preoperative vascular assessment, and postoperative monitoring are further supporting successful fistula creation and management. As the need for sustained dialysis care increases, arteriovenous fistulas are expected to remain a central procedure type while continuing to expand with the growing demand for long-term vascular access.
Application Segment Analysis: Hemodialysis (Largest & Fastest-Growing Segment)
In 2026, hemodialysis accounted for the largest share of 55% in the vascular access procedures market and is also expected to grow at the fastest rate during the forecast period. Hemodialysis requires dependable vascular access to enable repeated circulation of blood between the patient and dialysis equipment, making vascular access procedures essential to the delivery of ongoing treatment. The increasing prevalence of chronic kidney disease and kidney failure is expanding the population requiring regular hemodialysis, thereby strengthening demand for effective and durable vascular access. Healthcare providers are increasingly focused on maintaining access functionality, reducing treatment interruptions, and improving patient outcomes, which supports the use of established vascular access procedures for dialysis care. Improvements in dialysis infrastructure and wider availability of renal care services are also increasing opportunities for patients to receive continuing treatment. As patients require repeated dialysis sessions over extended periods, the need for reliable vascular access remains persistent. These factors are supporting the leading position of hemodialysis within the market and are expected to drive continued growth as demand for renal replacement therapy expands.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Procedure Type | Arteriovenous Fistulas, Arteriovenous Grafts, Central Venous Catheters, Others | Arteriovenous Fistulas | Arteriovenous Fistulas |
| Application | Chemotherapy, Hemodialysis, Blood Transfusions, Intravenous Antibiotics Treatment, Others | Hemodialysis | Hemodialysis |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Mitigating clinical risk remains the primary driver within the vascular access procedures market, where preventing bloodstream infections, thrombosis, and procedural complications is paramount. Broad adoption relies on pairing advanced biocompatible catheter materials—designed to balance conformability with kinking resistance—with real-time ultrasound and navigation-guided insertion tools that elevate placement accuracy. Concurrently, medical device manufacturers are refining non-invasive technologies and securement designs to minimize patient trauma and insertion discomfort. Market leadership consequently belongs to providers that can validate their safety innovations through robust clinical evidence while seamlessly integrating tools into standard clinical workflows.
Major players in the vascular access procedures market:
- Becton Dickinson (USA)
- B. Braun (Germany)
- Teleflex (USA)
- Medtronic (Ireland)
- Smiths Medical (UK)
- AngioDynamics (USA)
- Cook Medical (USA)
- Fresenius Medical Care (Germany)
- Nipro Corporation (Japan)
- Terumo (Japan)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Becton Dickinson (USA) | |||||||
| B. Braun (Germany) | |||||||
| Teleflex (USA) | |||||||
| Medtronic (Ireland) | |||||||
| Smiths Medical (UK) | |||||||
| AngioDynamics (USA) | |||||||
| Cook Medical (USA) | |||||||
| Fresenius Medical Care (Germany) | |||||||
| Nipro Corporation (Japan) | |||||||
| Terumo (Japan) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Navi | July 2026 | Navi secured A$6.8 million in funding to support the commercial deployment and market expansion of its pediatric medical technology in the U.S., advancing its vascular-access-related medtech offerings. |
| ENvue Medical | March 2026 | ENvue Medical introduced ENvue Drive, a robotic-assisted technology addressing combined enteral feeding and vascular access opportunities, targeting a market opportunity exceeding $10 billion and expanding its portfolio into robotic-assisted procedural applications. |
| PIV Assist | February 2025 | PIV Assist launched an AI-powered ultrasound system designed to facilitate peripheral intravenous procedure planning by providing real-time catheter-to-vein ratio calculations and pre-scan differentiation between veins and arteries. |
| BD | October 2024 | BD launched the BD Intraosseous Vascular Access System for emergency care, providing a direct bone marrow insertion method to establish rapid bloodstream access for fluid and medication delivery when traditional IV access is difficult or impossible. |
| Obvius Robotics | June 2024 | Obvius Robotics achieved an FDA Breakthrough Device designation for its Certa access system, supporting central venous catheterization development and providing a key regulatory milestone to improve accuracy, safety, and consistency in catheter placement. |
| Teleflex | May 2024 | Teleflex unveiled the Arrow EZ-IO Intraosseous Access Procedure Tray, a single-use sterile tray equipped with essential tools to streamline intraosseous access procedures and improve operational efficiency for medical practitioners. |
| B. Braun Medical Inc. | October 2023 | B. Braun Medical Inc. introduced the Introcan Safety 2 IV Catheter with Multi-Access Blood Control, incorporating an automatic needlestick protection mechanism and an integrated blood control system to lower bloodborne pathogen exposure risks. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Vascular Access Procedures Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Care Setting | Hospitals, Ambulatory Surgical Centers, Dialysis Centers, Specialty Clinics, Home Healthcare |
| Patient Age Group | Pediatric, Adult, Geriatric |
| Access Technique | Ultrasound-Guided Access, Landmark-Guided Access, Surgical Access |
Vascular Access Procedures Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Site-of-Care Shifts in Vascular Access |
|
| Catheter Selection & Utilization Pathways |
|
| Infection Prevention Adoption Strategies |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How large is the vascular access procedures market?
How is the vascular access procedures industry size expected to evolve during the forecast period?
How is the growing burden of chronic disease supporting vascular access demand?
How are device innovations improving adoption of vascular access procedures?
Why do arteriovenous fistulas dominate the vascular access procedures market?
What is driving growth in hemodialysis-related vascular access procedures?
How does North America maintain its leadership in the vascular access procedures market?
Why is Asia Pacific expected to grow fastest in the vascular access procedures market?
Who are the leading players in the vascular access procedures landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook